<HTML xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki  ltr ns-0 ns-subject page-Team_Slovenia_Results_Engineered_flagellin_vaccine_DNA_vaccine"><DIV id="globalWrapper"><DIV id="top-section"><DIV id="p-logo"><A href="/Main_Page" title="Main Page">&quot;
	    </A></DIV><DIV id="menubar" class="left-menu"><UL><LI class="selected"><A href="/Team:Slovenia/Results/Engineered_flagellin_vaccine/DNA_vaccine">Page               </A></LI><LI class="new"><A href="/wiki/index.php?title=Talk:Team:Slovenia/Results/Engineered_flagellin_vaccine/DNA_vaccine&amp;action=edit&amp;redlink=1">Discussion               </A></LI><LI><A href="/wiki/index.php?title=Team:Slovenia/Results/Engineered_flagellin_vaccine/DNA_vaccine&amp;action=edit">View source               </A></LI><LI><A href="/wiki/index.php?title=Team:Slovenia/Results/Engineered_flagellin_vaccine/DNA_vaccine&amp;action=history">History               </A></LI><LI style="color:#808080;cursor:default">teams</LI></UL></DIV><DIV class="right-menu" id="menubar"><UL><LI id="pt-login"><A href="/wiki/index.php?title=Special:UserLogin&amp;returnto=Team:Slovenia/Results/Engineered_flagellin_vaccine/DNA_vaccine" title="You are encouraged to log in; however, it is not mandatory [o]" accesskey="o">Log in</A></LI></UL></DIV><DIV id="search-controls"><FORM action="/Special:Search" id="searchform">Â </FORM></DIV></DIV><DIV id="content"><H1 class="firstHeading">Team:Slovenia/Results/Engineered flagellin vaccine/DNA vaccine</H1><DIV id="bodyContent"><H3 id="siteSub">From 2008.igem.org</H3><DIV align="center" style="width:900px; background-color:#528e68; text-align:center;"><UL id="sddm"><LI><DIV id="m1" onmouseover="mcancelclosetime()" onmouseout="mclosetime()"><A href="https://2008.igem.org/Team:Slovenia/Background/The_problem" target="_self">The problem</A><A href="https://2008.igem.org/Team:Slovenia/Background/Modern_vaccines" target="_self">Modern vaccines</A><A href="https://2008.igem.org/Team:Slovenia/Background/Immune_response" target="_self">Immune response</A><A href="https://2008.igem.org/Team:Slovenia/Background/Flagellin" target="_self">Flagellin</A></DIV></LI><LI><DIV id="m2" onmouseover="mcancelclosetime()" onmouseout="mclosetime()"><A href="https://2008.igem.org/Team:Slovenia/Project/Motivation" target="_self">Motivation</A><A href="https://2008.igem.org/Team:Slovenia/Project/Engineered_flagellin_vaccine" target="_self">Engineered flagellin vaccine</A><A href="https://2008.igem.org/Team:Slovenia/Project/Antigen-TLR_fusion_vaccine" target="_self">Antigen-TLR fusion vaccine</A></DIV></LI><LI><DIV id="m3" onmouseover="mcancelclosetime()" onmouseout="mclosetime()"><A href="https://2008.igem.org/Team:Slovenia/Results/Engineered_flagellin_vaccine" target="_self">Engineered flagellin vaccine</A><A href="https://2008.igem.org/Team:Slovenia/Results/Antigen-TLR_fusion_vaccine" target="_self">Antigen-TLR fusion vaccine</A><A href="https://2008.igem.org/Team:Slovenia/Results/Real-life_results" target="_self">&quot;Real-life&quot; results</A><A href="https://2008.igem.org/Team:Slovenia/Results/Biobricks" target="_self">Biobricks</A></DIV></LI><LI><DIV id="m4" onmouseover="mcancelclosetime()" onmouseout="mclosetime()"><A href="https://2008.igem.org/Team:Slovenia/Notebook/Methods" target="_self">Methods</A><A href="https://2008.igem.org/Team:Slovenia/Notebook/Safety" target="_self">Safety</A><A href="https://2008.igem.org/Team:Slovenia/Notebook/References" target="_self">References</A><A href="https://2008.igem.org/Team:Slovenia/Notebook/Notebook" target="_self">Notebook</A></DIV></LI><LI><DIV id="m5" onmouseover="mcancelclosetime()" onmouseout="mclosetime()"><A href="https://2008.igem.org/Team:Slovenia/Acknowledgements" target="_self">Acknowledgements</A><A href="https://2008.igem.org/Team:Slovenia/Sponsors" target="_self">Sponsors</A></DIV></LI></UL></DIV><P><CENTER><FONT size="6" color="#C73E4A"><I>DNA vaccine</I></FONT></CENTER></P><DIV style="text-align:justify">
To increase the immunogenicity of <I>H. pylori</I> antigens, we constructed fusion proteins with flagellin. Fusion flagellins with <I>H. pylori</I> antigens were tested as recombinant proteins expressed in bacteria (see Results - Modified bacteria as mucosal vaccines) as a delivery system, as well as a DNA vaccine.
<B>We tested several constructs listed below:</B><TABLE><TBODY><TR><TD style="border: 1pt solid windowtext; padding: 0cm 5.4pt; width: 153.5pt; background-color: transparent;" valign="top" width="205"><P class="MsoNormal" style="margin: 0cm 0cm 0pt;"><B><FONT size="3"><FONT color="#000000"><FONT face="Times New Roman">Construct name</FONT></FONT></FONT></B></P></TD><TD style="border-color: windowtext windowtext windowtext rgb(236, 233, 216); border-top: 1pt solid windowtext; border-right: 1pt solid windowtext; border-bottom: 1pt solid windowtext; padding: 0cm 5.4pt; width: 153.55pt; background-color: transparent;" valign="top" width="205"><P class="MsoNormal" style="margin: 0cm 0cm 0pt;"><B><FONT size="3"><FONT color="#000000"><FONT face="Times New Roman">vector</FONT></FONT></FONT></B></P></TD><TD style="border-color: windowtext windowtext windowtext rgb(236, 233, 216); border-top: 1pt solid windowtext; border-right: 1pt solid windowtext; border-bottom: 1pt solid windowtext; padding: 0cm 5.4pt; width: 153.55pt; background-color: transparent;" valign="top" width="205"><P class="MsoNormal" style="margin: 0cm 0cm 0pt;"><B><FONT size="3"><FONT color="#000000"><FONT face="Times New Roman">Biobrick number</FONT></FONT></FONT></B></P></TD></TR><TR><TD style="border-color: rgb(236, 233, 216) windowtext windowtext; border-left: 1pt solid windowtext; border-right: 1pt solid windowtext; border-bottom: 1pt solid windowtext; padding: 0cm 5.4pt; width: 153.5pt; background-color: transparent;" valign="top" width="205"><P class="MsoNormal" style="margin: 0cm 0cm 0pt;"><FONT size="3"><FONT color="#000000"><FONT face="Times New Roman"><B>CMV-ssCF</B></FONT></FONT></FONT></P></TD><TD style="border-color: rgb(236, 233, 216) windowtext windowtext rgb(236, 233, 216); border-right: 1pt solid windowtext; border-bottom: 1pt solid windowtext; padding: 0cm 5.4pt; width: 153.55pt; background-color: transparent;" valign="top" width="205"><P class="MsoNormal" style="margin: 0cm 0cm 0pt;"><FONT size="3"><FONT face="Times New Roman"><SPAN style="color: black;" lang="EN">BBa_J52017</SPAN></FONT></FONT></P></TD><TD style="border-color: rgb(236, 233, 216) windowtext windowtext rgb(236, 233, 216); border-right: 1pt solid windowtext; border-bottom: 1pt solid windowtext; padding: 0cm 5.4pt; width: 153.55pt; background-color: transparent;" valign="top" width="205"><P class="MsoNormal" style="margin: 0cm 0cm 0pt;"><FONT size="3"><FONT color="#000000"><FONT face="Times New Roman">BBa_K133021</FONT></FONT></FONT></P></TD></TR><TR><TD style="border-color: rgb(236, 233, 216) windowtext windowtext; border-left: 1pt solid windowtext; border-right: 1pt solid windowtext; border-bottom: 1pt solid windowtext; padding: 0cm 5.4pt; width: 153.5pt; background-color: transparent;" valign="top" width="205"><P class="MsoNormal" style="margin: 0cm 0cm 0pt;"><FONT size="3"><FONT color="#000000"><FONT face="Times New Roman"><B>CMV-ssCF-UreB</B></FONT></FONT></FONT></P></TD><TD style="border-color: rgb(236, 233, 216) windowtext windowtext rgb(236, 233, 216); border-right: 1pt solid windowtext; border-bottom: 1pt solid windowtext; padding: 0cm 5.4pt; width: 153.55pt; background-color: transparent;" valign="top" width="205"><P class="MsoNormal" style="margin: 0cm 0cm 0pt;"><FONT size="3"><FONT face="Times New Roman"><SPAN style="color: black;" lang="EN">BBa_J52017</SPAN></FONT></FONT></P></TD><TD style="border-color: rgb(236, 233, 216) windowtext windowtext rgb(236, 233, 216); border-right: 1pt solid windowtext; border-bottom: 1pt solid windowtext; padding: 0cm 5.4pt; width: 153.55pt; background-color: transparent;" valign="top" width="205"><P class="MsoNormal" style="margin: 0cm 0cm 0pt;"><FONT size="3"><FONT color="#000000"><FONT face="Times New Roman">BBa_K133024</FONT></FONT></FONT></P></TD></TR><TR><TD style="border-color: rgb(236, 233, 216) windowtext windowtext; border-left: 1pt solid windowtext; border-right: 1pt solid windowtext; border-bottom: 1pt solid windowtext; padding: 0cm 5.4pt; width: 153.5pt; background-color: transparent;" valign="top" width="205"><P class="MsoNormal" style="margin: 0cm 0cm 0pt;"><FONT size="3"><FONT color="#000000"><FONT face="Times New Roman"><B>CMV-ssCF-multi-CF</B></FONT></FONT></FONT></P></TD><TD style="border-color: rgb(236, 233, 216) windowtext windowtext rgb(236, 233, 216); border-right: 1pt solid windowtext; border-bottom: 1pt solid windowtext; padding: 0cm 5.4pt; width: 153.55pt; background-color: transparent;" valign="top" width="205"><P class="MsoNormal" style="margin: 0cm 0cm 0pt;"><FONT size="3"><FONT face="Times New Roman"><SPAN style="color: black;" lang="EN">BBa_J52017</SPAN></FONT></FONT></P></TD><TD style="border-color: rgb(236, 233, 216) windowtext windowtext rgb(236, 233, 216); border-right: 1pt solid windowtext; border-bottom: 1pt solid windowtext; padding: 0cm 5.4pt; width: 153.55pt; background-color: transparent;" valign="top" width="205"><P class="MsoNormal" style="margin: 0cm 0cm 0pt;"><FONT size="3"><FONT color="#000000"><FONT face="Times New Roman">BBa_K133023</FONT></FONT></FONT></P></TD></TR><TR><TD style="border-color: rgb(236, 233, 216) windowtext windowtext; border-left: 1pt solid windowtext; border-right: 1pt solid windowtext; border-bottom: 1pt solid windowtext; padding: 0cm 5.4pt; width: 153.5pt; background-color: transparent;" valign="top" width="205"><P class="MsoNormal" style="margin: 0cm 0cm 0pt;"><FONT size="3"><FONT color="#000000"><FONT face="Times New Roman"><B>CMV-CF-multi-CF</B></FONT></FONT></FONT></P></TD><TD style="border-color: rgb(236, 233, 216) windowtext windowtext rgb(236, 233, 216); border-right: 1pt solid windowtext; border-bottom: 1pt solid windowtext; padding: 0cm 5.4pt; width: 153.55pt; background-color: transparent;" valign="top" width="205"><P class="MsoNormal" style="margin: 0cm 0cm 0pt;"><FONT size="3"><FONT face="Times New Roman"><SPAN style="color: black;" lang="EN">BBa_J52017</SPAN></FONT></FONT></P></TD><TD style="border-color: rgb(236, 233, 216) windowtext windowtext rgb(236, 233, 216); border-right: 1pt solid windowtext; border-bottom: 1pt solid windowtext; padding: 0cm 5.4pt; width: 153.55pt; background-color: transparent;" valign="top" width="205"><P class="MsoNormal" style="margin: 0cm 0cm 0pt;"><FONT size="3"><FONT color="#000000"><FONT face="Times New Roman">BBa_K133020</FONT></FONT></FONT></P></TD></TR><TR><TD style="border-color: rgb(236, 233, 216) windowtext windowtext; border-left: 1pt solid windowtext; border-right: 1pt solid windowtext; border-bottom: 1pt solid windowtext; padding: 0cm 5.4pt; width: 153.5pt; background-color: transparent;" valign="top" width="205"><P class="MsoNormal" style="margin: 0cm 0cm 0pt;"><FONT size="3"><FONT color="#000000"><FONT face="Times New Roman"><B>CMV-ssUreB</B></FONT></FONT></FONT></P></TD><TD style="border-color: rgb(236, 233, 216) windowtext windowtext rgb(236, 233, 216); border-right: 1pt solid windowtext; border-bottom: 1pt solid windowtext; padding: 0cm 5.4pt; width: 153.55pt; background-color: transparent;" valign="top" width="205"><P class="MsoNormal" style="margin: 0cm 0cm 0pt;"><FONT size="3"><FONT face="Times New Roman"><SPAN style="color: black;" lang="EN">BBa_J52017</SPAN></FONT></FONT></P></TD><TD style="border-color: rgb(236, 233, 216) windowtext windowtext rgb(236, 233, 216); border-right: 1pt solid windowtext; border-bottom: 1pt solid windowtext; padding: 0cm 5.4pt; width: 153.55pt; background-color: transparent;" valign="top" width="205"><P class="MsoNormal" style="margin: 0cm 0cm 0pt;"><FONT size="3"><FONT color="#000000"><FONT face="Times New Roman">BBa_K133129</FONT></FONT></FONT></P></TD></TR></TBODY></TABLE><STRONG>Stimulation of TLR5 occurs only when chimeric flagellin is secreted.</STRONG>
HEK293 cells were co-transfected with TLR5, luciferase reporter plasmids and CMV-ss-CF-multi-CF or CMV-CF-multi-CF. Cells expresing only TLR5 were stimulated with flagellin from <I>S. typhimurium</I> (positive control) or with MQ (negative control). 6 h after stimulation, cells were lysed and luciferase activity was measured.
 

We found out that constructs without signal sequnce did not activate the TLR5 signaling pathway. This proves the hypothesis, that chimeric flagellin with  fused <I>H. pylori</I> antigens, had to be transported outside the cell to activate the TLR5 signaling pathway. To confirm these results we made further tests on cell lines (see TLR5 activation in mixed cell lines).
<STRONG>Activation of TLR5 requires flagellin, but is not affected by antigen adding. </STRONG>

HEK293 cells were co-transfected with TLR5, CMV-CF-multi-CF, CMV-ss-CF-UreB or CMV-ss-UreB and luciferase reporter plasmids. Cells expresing only TLR5 were stimulated with FliC from <I>S. typhimurium</I> (positive control) or with MQ (negative control). 6 h after stimulation, cells were lysed and luciferase activity was measured.

 

There has been activation of TLR5 with chimeric flagellin fused with antigen (multiepitope or urease B). On the other hand there was no activation with urease B. This proves, that chimeric flagellin is needed to activate TLR5 signaling and to stimulate immune response against <I>H. pylori</I> antigene. 

Taken together, for TLR5 activation secretion of chimeric flagellin is needed, whereas antigens do not affect flagellin's agonistic function.
<STRONG>TLR5 TRANSACTIVATION IN MIXED CELL CULTURES</STRONG> 

The main goal of this experiment was to find out if cells transfected with DNA coding for chimeric flagellin, activate the TLR5 signaling pathway in co-culture cells that expressed TLR5 on their surface.
<STRONG>Schematic illustration of expeimental design of cellular transactivation by chimeric flagellin DNA vaccine.</STRONG><STRONG>Chimeric flagellin DNA vaccine produced by transfected cells activates neighboring cells that express TLR5.</STRONG>
The purpose of this experiment was to demonstrate that introduction of DNA vaccine with chimeric flagellin into epithelial cells can trigger activation of near/underlying dendritic cells which have flagellin receptor TLR5 on their surface in vivo. The experiment was performed with a mixed culture of  HEK293 cells transfected with CMV-ss-CF-multi-CF DNA and HEK293 cells transfected with the TLR5 plasmid and reporter luciferase plasmids which detect its activation (green bar) (see also scheme above).
<STRONG>Pattern of cytokine production triggered by chimeric flagellin construct</STRONG>
 
Production of cytokines was determined by the muliplexing analysis on flow cytometer. DNA construct CMV-ss-CF-multi-CF produced the following concentrations of cytokines: 9 ng/ml IL-8, 4 ng/ml IL-6, 16 ng/ml IFN-alph and 30 ng/ml IL-1beta.
 
Multiplexing flow cytometric determination of cytokines IL-8, IL-6, IFN-alpha and IL-1beta in HEK293 cells transfected with TLR5 and CMV-ss-CF-multi-CF.
</DIV><DIV class="printfooter">
Retrieved from &quot;<A href="http://2008.igem.org/Team:Slovenia/Results/Engineered_flagellin_vaccine/DNA_vaccine">http://2008.igem.org/Team:Slovenia/Results/Engineered_flagellin_vaccine/DNA_vaccine</A>&quot;</DIV></DIV></DIV><DIV id="footer-box"><DIV id="footer"><UL id="f-list"><LI id="t-recentchanges"><A href="/Special:RecentChanges" title="Recent changes">Recent changes</A></LI><LI id="t-whatlinkshere"><A href="/Special:WhatLinksHere/Team:Slovenia/Results/Engineered_flagellin_vaccine/DNA_vaccine" title="List of all wiki pages that link here [j]" accesskey="j">What links here</A></LI><LI id="t-recentchangeslinked"><A href="/Special:RecentChangesLinked/Team:Slovenia/Results/Engineered_flagellin_vaccine/DNA_vaccine" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</A></LI><LI id="t-specialpages"><A href="/Special:SpecialPages" title="List of all special pages [q]" accesskey="q">Special pages</A></LI><LI><A href="/Special:Preferences">My preferences</A></LI></UL></DIV><DIV id="footer"><UL id="f-list"><LI id="t-print"><A href="/wiki/index.php?title=Team:Slovenia/Results/Engineered_flagellin_vaccine/DNA_vaccine&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</A></LI><LI id="t-permalink"><A href="/wiki/index.php?title=Team:Slovenia/Results/Engineered_flagellin_vaccine/DNA_vaccine&amp;oldid=105829" title="Permanent link to this revision of the page">Permanent link</A></LI><LI id="privacy"><A href="/2008.igem.org:Privacy_policy" title="2008.igem.org:Privacy policy">Privacy policy</A></LI><LI id="disclaimer"><A href="/2008.igem.org:General_disclaimer" title="2008.igem.org:General disclaimer">Disclaimers</A></LI></UL></DIV></DIV></DIV></BODY></HTML>